Impact BioMedical (IBO)

• Market cap: $58.4M
• 1 day: -14.03%
• 5 days: 21.46%
• 1 month: 29.77%
• 3 months: -16.65%
• 6 months: -65.34%
• Year to date: -63.77%
• 1 year: -61.25%
• 5 years: -79.18%
• 10 years: -79.18%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Employees: 8